Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 830 results for "novartis ag"

Pharma companies in consonance with implementing revised drug

The Centre on Thursday told the Delhi High Court that pharmaceutical companies, including Novartis India Limited and Cipla Ltd, appear to be in "consonance" with implementation of the revised drug pricing and the two sides are "very close" to resolving the ... DNA, 9 minutes ago

9 images for novartis ag

North Jersey.com, 1 day ago
PharmaceuticalProcessing, 1 day ago
University of Ottawa Fulcrum, 1 week ago
Centre For Infectious Disease Research and Policy, 2 days ago
Centre For Infectious Disease Research and Policy, 2 days ago
BusinessWeek, 1 week ago
Yahoo! UK and Ireland, 2 weeks ago
FinanzNachrichten.de, 2 weeks ago
FinanzNachrichten.de, 3 weeks ago
Livemint.com

Cancel Novartis patents on respiratory drug: Cipla

MUMBAI: Generic drugmaker Cipla Ltd said on Thursday it had requested the Indian government to revoke five patents held by Swiss firm Novartis AG on respiratory drug Onbrez, to boost its access in the Indian market. Cipla alleged that Novartis has ...
 Economic Times3 hours ago Cipla asks government to revoke Novartis patents on respiratory drug  Yahoo! Finance4 hours ago Cipla asks India to revoke Novartis patents on respiratory drug  Business Standard53 minutes ago UPDATE 1-Cipla asks India to revoke Novartis patents on respiratory drug  Reuters1 hour ago
[x]  
Business Spectator

Novartis net profit jumps by 45% in Q3 to $3.2 bn

Novartis International AG, a world leader in the pharmaceutical segment, has posted strong financial performance during the third quarter ended September 2014. Its net earnings went up sharply by 45.1 per cent to $3,240 million from $2,233 million ...
 PharmaBiz5 hours ago Swiss drug maker Novartis posts strong 3Q profit  FOXBusiness.com2 days ago Novartis posts 45% lift in Q3 profit  Business Spectator2 days ago Swiss drug maker Novartis posts 3Q profit  Herald Sun2 days ago
[x]  
Reuters UK

Novartis delivered solid sales growth with strong margin expansion and major innovation in the third quarter

Novartis International AG / . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Net sales up 4% (+5% cc)[1] in Q3, with operating margin increase across Q3 and 9M ...
 BusinessWeek2 days ago CSL to acquire influenza vaccines business from Novartis  Individual.com2 days ago Novartis Sells Its Low-Margin Influenza Vaccine Business  Bidness Etc3 days ago Novartis results top forecasts as new products gain momentum  Sharenet2 days ago
[x]  
Livemint.com

Novartis Profit Beats Estimates as New Drugs Offset Diovan

(Updates with analyst comment in fourth paragraph.) Oct. 28 (Bloomberg) -- Novartis AG, the world's biggest drugmaker by sales, reported third-quarter profit that beat analysts estimates as revenue growth in new drugs more than offset sales lost ...
 La Repubblica2 days ago

MorphoSys receives clinical milestone in ophthalmology programme from Novartis

MorphoSys AG has received a milestone payment from Novartis in connection with the initiation of a phase 1 clinical trial of a HuCAL antibody in the field of diabetic eye diseases. This becomes the ninth therapeutic antibody made using MorphoSys's ...
 PharmaBiz1 week ago MorphoSys Receives Milestone Payment From Novartis On Initiation Of HuCAL Trial  RTTNews.com1 week ago BRIEF-Morphosys says received a milestone payment from Novartis  Reuters1 week ago

Novartis 3Q 2014 -- Forecast

Novartis (NYSE:NVS) Intraday Stock Chart Today : Thursday 23 October 2014 FRANKFURT--The following is a summary of analysts' forecasts for Novartis AG (NVS) third-quarter results, based on a poll of nine analysts conducted by Dow Jones ...
 ADVFN India1 week ago
[x]  

Novartis Drags DRL to Court over Gleevec

HYDERABAD: Basel-headquartered Novartis Pharmaceuticals Corporation and Novartis AG dragged city-based Dr Reddy's Laboratories Ltd (DRL) and its US subsidiary Dr Reddy's Laboratories Inc to the US court over alleged patent infringement. As per ...
 New Indian Express1 week ago
Money Control

Natco pharma's US partner files ANDA for Everolimus

Novartis AG sells Everolimus 0.25mg, 0.5mg, and 0.75mg Tablets under Brand name Zortress in the USA market.
 Money Control1 month ago Natco's partner Breckenridge files ANDA for Everolimus tablets  Myiris1 month ago

Swiss Stocks Rally Led By UBS, Novartis Earnings

Swiss stocks emerged from recent slumber on Tuesday, rising sharply following strong earnings reports from UBS and Novartis. The Swiss Market Index rose 1.29 percent, and is outperforming other European markets by rising more than 7.5 percent ...
 RTTNews.com1 day ago European Stocks Head for Three-Week High as Novartis, UBS Rally  La Repubblica1 day ago European Stocks Rise First Time in Three Days as Novartis Gains  Washington Post2 days ago Europe Stocks Gain First Time in Three Days as UBS Jumps  BusinessWeek1 day ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less